Destruction of Hazardous Imports Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
Expands FDA authority to destroy refused imported articles that present significant public health concerns and bars unauthorized movement of articles slated for destruction.
Who Benefits and How
Consumers and public health regulators could gain stronger tools to keep dangerous imported articles out of commerce.
Who Bears the Burden and How
Importers of refused articles could face more destruction risk and tighter handling restrictions, while FDA would have to update regulations and implement the new authority.
Key Provisions
- Allows destruction of any refused imported article that HHS determines presents a significant public health concern.
- Extends related statutory references beyond drugs and devices to other refused articles.
- Makes unauthorized movement of articles designated for destruction unlawful and requires implementing regulations within 90 days.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Expands FDA authority to destroy refused imported articles that present significant public health concerns and bars unauthorized movement of articles slated for destruction.
Key Policy Areas
Healthcare, Trade, Government Operations
Primary Purpose
Expands FDA authority to destroy refused imported articles that present significant public health concerns and bars unauthorized movement of articles slated for destruction.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Consumers and public health regulators seeking stronger controls on hazardous imports
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Importers of refused articles subject to destruction authority
- FDA officials implementing the revised regulations
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMr. Scott of Florida introduced the following bill; which was …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Importers of refused articles subject to broader destruction authority
FDA officials updating and administering the rules
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology